Stimcell Energetics (STME) Free Cash Flow Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Free Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.66% |
| Nov 30, 2025 | 12.45% |
| Aug 31, 2025 | 8.78% |
| May 31, 2025 | 24.00% |
| Feb 28, 2025 | 27.35% |
| Nov 30, 2024 | 43.05% |
| Aug 31, 2024 | 35.55% |
| May 31, 2024 | 20.57% |
| Feb 29, 2024 | 23.21% |
| Nov 30, 2023 | -13.49% |
| Aug 31, 2023 | 2.83% |
| May 31, 2023 | 3.59% |
| Feb 28, 2023 | -3.88% |
| Nov 30, 2022 | 21.38% |
| Aug 31, 2022 | 6.93% |
| May 31, 2022 | 13.38% |
| Feb 28, 2022 | 19.03% |
| Nov 30, 2021 | 16.03% |
| Aug 31, 2021 | -1.83% |
| May 31, 2021 | 11.28% |